Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05432895 · ClinicalTrials.gov registry record · NA

Dynamic Versus Static Night Splinting of Plantar Fasciitis

A NA study of Plantar Fascitis, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT05432895: Recruiting NA study of Plantar Fascitis, sponsored by Stanford University.

NCT05432895 is a NA study of Plantar Fascitis that is actively recruiting participants, run by Stanford University. The registered enrollment target is 200 participants, above the 67-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (199% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05432895, a NA study of Plantar Fascitis, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

The investigators are trying to study that there is no difference in improvement of motion between static progressive and dynamic splinting.

Primary Outcome

We plan to use VAS pain scale as measurement scale ( range; 0-10, higher scores correspond to greater pain)

Conditions Studied

Interventions

  • DEVICE Dynamic splint

Study Locations (2)

California

  • Stanford University School of Medicine - Palo Alto
  • Stanford outpatient center - Redwood City

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-10-31
Est. Completion 2026-06-18
Phase NA
Stanford University

1,744 total trials

What NCT05432895 shows while recruiting

NCT05432895 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 67-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (199% higher).

The record links to 1 condition, with Plantar Fascitis appearing as the primary indexed condition, and to 1 intervention - of which Dynamic splint is the first listed.

NCT05432895 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05432895 about?

NCT05432895 is a clinical study titled "Dynamic Versus Static Night Splinting of Plantar Fasciitis". The investigators are trying to study that there is no difference in improvement of motion between static progressive and dynamic splinting.

What is the current status of trial NCT05432895?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-10-31. Estimated completion is 2026-06-18.

What conditions does trial NCT05432895 study?

This clinical trial studies the following conditions: Plantar Fascitis.

What interventions are being tested in trial NCT05432895?

The interventions under investigation include: Dynamic splint (DEVICE).

Who is sponsoring clinical trial NCT05432895?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05432895 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Plantar Fascitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05432895, the US trial registry maintained by the National Library of Medicine. NCT05432895 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.